Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Bergestuen, Deidi S ^a,c   Gravning, Jørgen ^a,c   Haugaa, Kristina H ^a,c   Sahakyan, Laura G ^a   Aakhus, Svend ^a   Thiis Evensen, Espen ^a   Øie, Erik ^a,b   Aukrust, Pål ^a,b,c   Attramadal, Håvard ^a,c   Edvardsen, Thor ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARCINOID SYNDROME; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART RIGHT VENTRICLE FAILURE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PROTEIN BLOOD LEVEL; PULMONARY VALVE INSUFFICIENCY; SENSITIVITY AND SPECIFICITY; SYSTOLE; TRICUSPID VALVE REGURGITATION; BLOOD; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; HEART DISEASE; HEART RIGHT VENTRICLE FUNCTION; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CONNECTIVE TISSUE GROWTH FACTOR; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PULMONARY VALVE INSUFFICIENCY; REGRESSION ANALYSIS; TRICUSPID VALVE INSUFFICIENCY; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 76749160318     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-6     Document Type: Article

References (44)

1. Connolly HM, Pellikka PA. Carcinoid heart disease. Curr Cardiol Rep 2006, 8:96-101. 10.1007/s11886-006-0019-9, 16524535.
2. Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993, 87:1188-1196.
3. Jacobsen MB, Nitter-Hauge S, Bryde PE, Hanssen LE. Cardiac manifestations in mid-gut carcinoid disease. Eur Heart J 1995, 16 (2):263-268.
4. Zuetenhorst JM, Korse CM, Bonfrer JM, Bakker RH, Taal BG. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease. Br J Cancer 2004, 90:2073-2079. 2409483, 15150565.
5. Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?. Matrix Biol 2002, 21:473-482. 10.1016/S0945-053X(02)00055-0, 12392758.
6. Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006, 119:4803-4810. 10.1242/jcs.03270, 17130294.
7. Cheng O, Thuillier R, Sampson E, Schultz G, Ruiz P, Zhang X, Yuen PST, Mannon RB. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006, 6:2292-2306. 10.1111/j.1600-6143.2006.01493.x, 16889607.
8. Leask A. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis. Keio J Med 2004, 53:74-77. 10.2302/kjm.53.74, 15247510.
9. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V, Gauthier JM, Ba N, Sobesky R, Ratziu V, Bedossa P. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999, 30:968-976. 10.1002/hep.510300425, 10498649.
10. Rachfal A, Brigstock D. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatology Res 2003, 26:1-9.
11. Vozenin-Brotons MC, Milliat F, Sabourin JC, De Gouville AC, Francois A, Lasser P, Morice P, Haie-Meder C, Lusinchi A, Antoun S, Bourhis J, Mathé D, Girinsky T, Aigueperse J. Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression. Int J Radiat Oncol Biol Phys 2003, 56:561-572. 10.1016/S0360-3016(02)04601-1, 12738334.
12. Ahmed MS, Øie E, Vinge LE, Yndestad A, Andersen G, Andersson Y, Attramadal T, Attramadal H. Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol 2004, 36:393-404. 10.1016/j.yjmcc.2003.12.004, 15010278.
13. Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, Kurabayashi M. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 2007, 49:1120-1127. 10.1161/HYPERTENSIONAHA.106.077537, 17372041.
14. Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, Sandusky GE, Pechous PA, Vlahos CJ, Wakasaki H, King GL. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes 2002, 51:2709-2718. 10.2337/diabetes.51.9.2709, 12196463.
15. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000, 32:1805-1819. 10.1006/jmcc.2000.1215, 11013125.
16. Kidd M, Modlin IM, Shapiro MD, Camp RL, Mane SM, Usinger W, Murren JR. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol 2007, 13:5208-5216.
17. Lindqvist P, Calcutteea A, Henein M. Echocardiography in the assessment of right heart function. Eur J Echocardiogr 2008, 9:225-234.
18. Matthews JC, Dardas TF, Dorsch MP, Aaronson KD. Right-sided heart failure: diagnosis and treatment strategies. Curr Treat Options Cardiovasc Med. 2008, 10(4):329-341.
19. Pettersen E, Helle-Valle T, Edvardsen T, Lindberg H, Smith HJ, Smevik B, Smiseth OA, Andersen K. Contraction pattern of the systemic right ventricle shift from longitudinal to circumferential shortening and absent global ventricular torsion. J Am Coll Cardiol 2007, 49:2450-2456. 10.1016/j.jacc.2007.02.062, 17599609.
20. Eriksson B, Oberg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion 2000, 62(suppl 1):33-38. 10.1159/000051853, 10940685.
21. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2006, 48:e1-e148. 10.1016/j.jacc.2006.05.021, 16875962.
22. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003, 16:777-802. 10.1016/S0894-7317(03)00335-3, 12835667.
23. Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 1995, 92:790-795.
24. Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, Støylen A, Ihlen H, Lima JAC, Smiseth OA, Slørdahl SA. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. JAm Coll Cardiol 2006, 47:789-793.
25. Helle-Valle T, Crosby J, Edvardsen T, Lyseggen E, Amundsen BH, Smith HJ, Rosen BD, Lima JAC, Torp H, Ihlen H, Smiseth OA. New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 2005, 112:3149-3156. 10.1161/CIRCULATIONAHA.104.531558, 16286606.
26. Gjesdal O, Hopp E, Vartdal T, Lunde K, Helle-Valle T, Aakhus S, Smith HJ, Ihlen H, Edvardsen T. Global longitudinal strain measured by two-dimensional speckle tracking echocardiography is closely related to myocardial infarct size in chronic ischaemic heart disease. Clin Sci (Lond) 2007, 113:287-296. 10.1042/CS20070066, 17501720.
27. Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 2004, 17:630-633. 10.1016/j.echo.2004.02.011, 15163933.
28. Teske AJ, De Boeck BWL, Olimulder M, Prakken NH, Doevendans PAF, Cramer MJ. Echocardiographic assessment of regional right ventricular function: a head-to-head comparison between 2-dimensional and tissue Doppler-derived strain analysis. J Am Soc Echocardiogr 2008, 21:275-283. 10.1016/j.echo.2007.08.027, 17961979.
29. Kjaergaard J, Svendsen JH, Sogaard P, Chen X, Nielsen HB, Køber L, Kjaer A, Hassager C. Advanced quantitative echocardiography in arrhythmogenic right ventricular cardiomyopathy. J Am Soc Echocardiogr 2007, 20:27-35. 10.1016/j.echo.2006.07.006, 17218199.
30. Kirkwood BR, Sterne JAC. Essential medical statistics 2003, Malden, MA: Blackwell Science, 2.
31. Dziadzio M, Usinger W, Leask A, Abraham D, Black CM, Denton C, Stratton R. N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM 2005, 98:485-492. 10.1093/qjmed/hci078, 15955800.
32. de Winter P, Leoni P, Abraham D. Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 2008, 26:80-91. 10.1080/08977190802025602, 18428027.
33. He S, Chen Y, Khankan R, Barron E, Burton R, Zhu D, Ryan SJ, Oliver N, Hinton DR. Connective tissue growth factor as a mediator of intraocular fibrosis. Invest Ophthalmol Vis Sci 2008, 49:4078-4088. 10.1167/iovs.07-1302, 2667831, 18450591.
34. Gressner AM, Yagmur E, Lahme B, Gressner O, Stanzel S. Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem 2006, 52:1815-1817. 10.1373/clinchem.2006.070466, 16858074.
35. Kubota S, Kawata K, Yanagita T, Doi H, Kitoh T, Takigawa M. Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem 2004, 136:279-282. 10.1093/jb/mvh126, 15598883.
36. Cicha I, Garlichs CD, Daniel WG, Goppelt-Struebe M. Activated human platelets release connective tissue growth factor. Thromb Haemost 2004, 91:755-760.
37. Hahn A, Heusinger-Ribeiro J, Lanz T, Zenkel S, Goppelt-Struebe M. Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton. J Biol Chem 2000, 275:37429-37435. 10.1074/jbc.M000976200, 10976101.
38. Kasho M, Sakai M, Sasahara T, Anami Y, Matsumura T, Takemura T, Matsuda H, Kobori S, Shichiri M. Serotonin enhances the production of type IV collagen by human mesangial cells. Kidney Int 1998, 54:1083-1092. 10.1046/j.1523-1755.1998.00114.x, 9767524.
39. Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun J, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 2000, 57:75-81.
40. Roy A, Brand NJ, Yacoub MH. Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves. J Heart Valve Dis 2000, 9:256-260.
41. Jaffre F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S, Monassier L, Mettauer B, Blaxall BC, Launay JM, Maroteaux L. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res 2009, 104:113-123. 10.1161/CIRCRESAHA.108.180976, 19023134.
42. Hafizi S, Taylor PM, Chester AH, Allen SP, Yacoub MH. Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. J Heart Valve Dis 2000, 9:454-458.
43. Waltenberger J, Lundin L, Öberg K, Wilander E, Miyazono K, Heldin CH, Funa K. Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 1993, 142:71-78. 1886850, 8424467.
44. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, Spagnolo P, Pantelidis P, Leoni P, McHugh N, Stock CJ, Shi-Wen X, Denton CP, Black CM, Wsh KI, du Bois RM, Abraham DJ. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 2007, 357:1210-1220. 10.1056/NEJMoa067655, 17881752.